Advertisement

Topics

Beactica AB Company Profile

07:06 EDT 23rd September 2017 | BioPortfolio

Beactica AB is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the biophysical interaction of molecules in order to generate novel therapeutics. Beactica's Sprint(TM) drug discovery platform efficiently integrates surface plasmon resonance (SPR) to accelerate the identification of optimal starting points and development routes for lead discovery. The company was spun out of Uppsala University in August 2006. As well as building collaborations with external companies, Beactica is progressing its own drug discovery programmes of small molecule therapeutics. For more information about Beactica, please visit http://www.beactica.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

Beactica Partners with Uppsala University, SciLifeLab on Study of Glioblastoma Compounds

Beactica said today it will partner with Uppsala University and the Drug Discovery and Development Platform at the SciLifeLab research laboratory to study the effect of small molecules being developed...

Beactica Announces Glioblastoma Research Collaboration With Uppsala Universitet And The DDD Platform At

  Life Sciences Jobs   ...

Beactica Announces Glioblastoma Research Collaboration with Uppsala University and the DDD Platform at SciLifeLab

Uppsala, Sweden, May 16, 2017 / B3C newswire / -- Beactica AB, the Swedish drug discovery company, today announced a new research collaboration with Uppsala University and the Drug Discovery and Deve...

Beactica AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250

SummaryBeactica AB Beactica is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragmentbased lead generation, kinetic ...

Global Fragmentbased Drug Discovery Market Research Report Forecast 20172022 [Report Updated: 05072017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Fragmentbased Drug Discovery Market Research Report Forecast 20172022 is a valuable source of insightful data for business...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Beactica AB

Beactica AB is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the biophysical interaction of molecules in order to generate novel therapeutics. Beactica's...

More Information about "Beactica AB" on BioPortfolio

We have published hundreds of Beactica AB news stories on BioPortfolio along with dozens of Beactica AB Clinical Trials and PubMed Articles about Beactica AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Beactica AB Companies in our database. You can also find out about relevant Beactica AB Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record